| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
7 companies
New Enterprise Associates 13 LP serves as a 10% Owner at COUR and has filed Form 4s across 7 companies. Across recent SEC filings that breaks down to 2 buys and 9 sells. Those positions are worth an estimated $7.7M at current prices.
Historically, New Enterprise Associates 13 LP's trades have earned a middling insider score of 68/100 across 9 rated trades. Over a 12-month horizon, 88.9% of those trades were profitable, with an average 12-month return of +46.8%.
The biggest single holding is BZFD (~$7.7M) as 10% Owner. The recent filings there lean toward selling, a net 431,974 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | BZFD Buzzfeed, Inc. | 10% Owner | Sell | 362,966 | $2.20 | $798,005.75 | -9.6% | +2.7% | -68.2% | |
| Mar 11, 2025 | BZFD Buzzfeed, Inc. | 10% Owner | Sell | 47,477 | $2.03 | $96,221.81 | -1.2% | +12.9% | -60.8% | |
| Mar 6, 2025 | BZFD Buzzfeed, Inc. | 10% Owner | Sell | 21,531 | $2.07 | $44,615.90 | -0.6% | +6.0% | -60.9% | |
| Jul 18, 2023 | SGMT Sagimet Biosciences Inc. | 10% Owner | Sell | 662 | $16.00 | $10,592.00 | - | -63.0% | -78.7% | |
| Jul 18, 2023 | SGMT Sagimet Biosciences Inc. | 10% Owner | Buy | 30,000 | $16.00 | $480,000.00 | +0.8% | -63.0% | -78.7% | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner | Buy | 550,000 | $17.00 | $9,350,000.00 | +12.6% | - | - |